BOPA Social Media & Communication Preferences Survey
Dear BOPA member, The BOPA digital subcommittee is conducting a short survey to better understand how pharmacy healthcare professionals working in oncology use social media and how they prefer to…
Dear BOPA member, The BOPA digital subcommittee is conducting a short survey to better understand how pharmacy healthcare professionals working in oncology use social media and how they prefer to…
We’re delighted to share that the BOPA abstracts presented at the 28th Annual BOPA Conference have now been published in the Journal of Oncology Pharmacy Practice. Huge congratulations to everyone…
We are inviting pharmacy professionals working in UK cancer services to take part in our study. What this research is about? To explore how pharmacy teams optimise medication for older…
The 2026 PRUK funding round launched on 24th November 2025 and will close at 1pm on 25th March 2026. BOPA-PRUK Research Award – NOW OPEN for Applications 2026 This award provides pharmacy professionals…
The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…
The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…
Over the last year, there have been numerous requests through the BOPA Education and Training Committee for communication skills training for Pharmacists. Anecdotally, this reflects the advanced roles that more…
I’m excited to share that the ISOPP International Symposium 2026 is now open for abstract submissions! This 24-hour virtual event takes place on March 20, 2026, and will bring together…
We are inviting healthcare professionals to take part in a short survey as part of the SWITCH study, a research project funded by the National Institute for Health and Care…
Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…
Are you working on an innovative oncology pharmacy project, service evaluation, or research study? Here’s your chance to share it with a global audience! Submit your abstract(s) online by Friday,…